Mpox
Mpox epidemiology, vaccination and treatment.
Key point
Paediatric mpox shows variable PCR positivity, progressive skin lesions and fever, with younger children more susceptible to severe complications.
From: Epidemiology and clinical manifestation of mpox in children: Systematic review and meta-analysis (Glob Public Health, 2026 Dec 31) ↗Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 12, 22, 9, 20, 13.
New guidelines and consensus this year
All papers from the last 12 months
1,116 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Recycled additive manufacturing filaments with mixed carbon (nano)materials for human monkeypox virus detectionTalanta2027 Feb 1PMID 42772051
- ROS-responsive hydrogel nanoarmor enables stepwise photodynamic viral inactivation and sustained anti-inflammation for monkeypox therapyBiomaterials2027 FebPMID 42600512
- Epidemiology and clinical manifestation of mpox in children: Systematic review and meta-analysisGlob Public Health2026 Dec 31PMID 41922934Meta-analysisSystematic review
- 'Outbreak distress': Characterising moral distress among international healthcare workers responding to mpoxGlob Public Health2026 Dec 31PMID 41629257
- Mosaic switch for PAM-free and one-pot CRISPR/Cas12a detectionBiosens Bioelectron2026 Dec 15PMID 42696818
- Rapid diagnosis, genome sequencing and culture isolation of a monkeypox virus of clade Ib from a Ugandan during a professional stay in FranceIJID Reg2026 DecPMID 42828108
- Comparative pathogenicity study of monkeypox virus Clade Ib and Clade IIb in a rabbit modelVirulence2026 DecPMID 42778521
- Serologic evidence of mpox virus exposure among people living with human immunodeficiency virus in Thailand predating clinical recognition during the 2022 outbreakIJID Reg2026 DecPMID 42774934
- Differential pathogenesis and antiviral treatment outcomes of MPXV clade Ib and clade IIb in a BALB/c mouse modelEmerg Microbes Infect2026 DecPMID 42748357
- Discovery of the nucleoside analogue FMAU as a broad-spectrum anti-orthopoxvirus inhibitor in vitro and in vivo using a structure-guided hit expansion strategyEmerg Microbes Infect2026 DecPMID 42742160
More infectious diseases trends
All specialties →New antibiotics for resistant Gram-negatives
Cefiderocol, sulbactam-durlobactam and other new agents.
Shorter regimens for tuberculosis
Bedaquiline, pretomanid and other shorter TB regimens.
Key point: For adolescents aged 14 years and above and adults with MDR/RR-TB, 6-month BPaLM is recommended over 9-month or longer regimens.
H5N1 avian influenza
H5N1 bird flu in animals and humans.
Dengue
Dengue spread, vaccines and treatment.
Doxy-PEP
Doxycycline after sex to prevent bacterial sexually transmitted infections.
Oral step-down for serious infections
Switching to oral antibiotics in endocarditis, bacteraemia and bone infection.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
mpox[tiab] OR monkeypox[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.